Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Margolis

Showing results (181-190 of 219) with videos related to

Pageof 22
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|November 16, 2011
No effect of raltegravir intensification on viral replication markers in the blood of HIV-1-infected patients receiving antiretroviral therapyRajesh T Gandhi, Robert W Coombs, Ellen S Chan, et al.
AIDS (London, England)|August 11, 2020
Efficacy, pharmacokinetics and neurocognitive performance of dual, NRTI-sparing antiretroviral therapy in acute HIV-infectionCynthia L Gay, Dayna T Neo, Aaron S Devanathan, et al.
Pathogens & Immunity|September 27, 2016
A Cure for HIV Infection: "Not in My Lifetime" or "Just Around the Corner"?Michael M Lederman, Paula M Cannon, Judith S Currier, et al.
AIDS Research and Human Retroviruses|June 22, 2017
Immunogenicity of AGS-004 Dendritic Cell Therapy in Patients Treated During Acute HIV InfectionCynthia L Gay, Mark A DeBenedette, Irina Y Tcherepanova, et al.
Plos Pathogens|February 29, 2024
The timing of HIV-1 infection of cells that persist on therapy is not strongly influenced by replication competency or cellular tropism of the provirusSarah B Joseph, Melissa-Rose Abrahams, Matthew Moeser, et al.
Biorxiv : the Preprint Server for Biology|February 24, 2025
NF-κB dependent gene expression and plasma IL-1β, TNFα and GCSF drive transcriptomic diversity and CD4:CD8 ratio in people with HIV on ARTYingfan Wang, German G Gornalusse, David A Siegel, et al.
Elife|October 6, 2020
The HIV-1 latent reservoir is largely sensitive to circulating T cellsJoanna A Warren, Shuntai Zhou, Yinyan Xu, et al.
Journal of Virology|February 11, 2021
CD8 lymphocyte depletion enhances the latency reversal activity of the SMAC mimetic AZD5582 in ART-suppressed SIV-infected rhesus macaquesMaud Mavigner, Laura E Liao, Alyssa D Brooks, et al.
Journal of Virology|December 28, 2020
Sequence Evaluation and Comparative Analysis of Novel Assays for Intact Proviral HIV-1 DNAChristian Gaebler, Shane D Falcinelli, Elina Stoffel, et al.
Plos Pathogens|January 14, 2014
Targeted cytotoxic therapy kills persisting HIV infected cells during ARTPaul W Denton, Julie M Long, Stephen W Wietgrefe, et al.
Pageof 22

Showing results (181-190 of 219) with videos related to

Sort By:
Pageof 22
Journal of Acquired Immune Deficiency Syndromes (1999)|November 16, 2011
No effect of raltegravir intensification on viral replication markers in the blood of HIV-1-infected patients receiving antiretroviral therapyRajesh T Gandhi, Robert W Coombs, Ellen S Chan, et al.
AIDS (London, England)|August 11, 2020
Efficacy, pharmacokinetics and neurocognitive performance of dual, NRTI-sparing antiretroviral therapy in acute HIV-infectionCynthia L Gay, Dayna T Neo, Aaron S Devanathan, et al.
Pathogens & Immunity|September 27, 2016
A Cure for HIV Infection: "Not in My Lifetime" or "Just Around the Corner"?Michael M Lederman, Paula M Cannon, Judith S Currier, et al.
AIDS Research and Human Retroviruses|June 22, 2017
Immunogenicity of AGS-004 Dendritic Cell Therapy in Patients Treated During Acute HIV InfectionCynthia L Gay, Mark A DeBenedette, Irina Y Tcherepanova, et al.
Plos Pathogens|February 29, 2024
The timing of HIV-1 infection of cells that persist on therapy is not strongly influenced by replication competency or cellular tropism of the provirusSarah B Joseph, Melissa-Rose Abrahams, Matthew Moeser, et al.
Biorxiv : the Preprint Server for Biology|February 24, 2025
NF-κB dependent gene expression and plasma IL-1β, TNFα and GCSF drive transcriptomic diversity and CD4:CD8 ratio in people with HIV on ARTYingfan Wang, German G Gornalusse, David A Siegel, et al.
Elife|October 6, 2020
The HIV-1 latent reservoir is largely sensitive to circulating T cellsJoanna A Warren, Shuntai Zhou, Yinyan Xu, et al.
Journal of Virology|February 11, 2021
CD8 lymphocyte depletion enhances the latency reversal activity of the SMAC mimetic AZD5582 in ART-suppressed SIV-infected rhesus macaquesMaud Mavigner, Laura E Liao, Alyssa D Brooks, et al.
Journal of Virology|December 28, 2020
Sequence Evaluation and Comparative Analysis of Novel Assays for Intact Proviral HIV-1 DNAChristian Gaebler, Shane D Falcinelli, Elina Stoffel, et al.
Plos Pathogens|January 14, 2014
Targeted cytotoxic therapy kills persisting HIV infected cells during ARTPaul W Denton, Julie M Long, Stephen W Wietgrefe, et al.
Pageof 22